Earnings call: Johnson & Johnson posts solid Q1 growth, eyes M&A strategy
Johnson & Johnson (JNJ), a global healthcare giant, reported a 3.9% increase in worldwide sales, hitting $21.4 billion for the first quarter of 2024. The U.S. market saw a 7.8% increase, although international sales slightly declined by 0.3%. Excluding the COVID-19 vaccine impact, operational sales growth was 7.6% worldwide.